Answer
Perjeta (pertuzumab) is contraindicated in patients with hypersensitivity to pertuzumab or any excipient listed in section 6.1 of its SmPC.
Sources for this answer
- Perjeta 420 mg Concentrate for Solution for InfusionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 22Document updated
Sources checked